Welcome! This is a past event. Watch the recording using the link and entering the following passcode: y$EZ6Y!n. The presentation slides are also available.
When: 14 November, 2022. 14h00 - 16h00. Geneva time (CET)
Topic: Open session day – 4th SAGE IVD meeting
Language: English
WHO launched the first edition of the Model List of Essential In Vitro Diagnostics (EDL) in May 2018. This was followed by two further editions, in 2019 and 2021.
The goal of the EDL is to help countries advance UHC, address health emergencies and promote healthier populations by supporting IVD policy development to improve people access to IVD testing and clinical laboratory services.
The Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) will hold its fourth meeting from 14 – 18 November 2022 in a virtual format. On the first day of the meeting, the EDL Secretariat has planned for an Open Session in the format of a Webinar. Participants will have the opportunity to submit questions and comments through Zoom's "Q&A" feature during the Q&A session. The language of the webinar will be English.
The main objectives of this 2022 SAGE IVD meeting will be to provide recommendations for the next edition of the WHO Model List of Essential In vitro Diagnostics (the EDL 4) and to review progress on the development of national EDLs.
Agenda
Time | Session | Speaker |
14h00 – 14h02 | Welcome to the webinar | Dr Francis Moussy Lead, Secretariat of the WHO Model List of Essential In Vitro Diagnostics, WHO HQ |
14h02 – 14h07 | Opening remarks | Dr Mariângela Simão Assistant Director-General, Access to Medicines and Health Products division, WHO HQ |
14h07 – 14h12 | Introduction to objectives of the 4th SAGE IVD meeting and the EDL 4 | Dr Francis Moussy Lead, Secretariat of the WHO Model List of Essential In Vitro Diagnostics, WHO HQ |
14h12 – 14h37 | EDL: overview, scope and methodology for its review and update | Dr Ana Aceves Capri Technical Officer, WHO EDL Secretariat, WHO HQ |
14h38 – 15h10 | The EDL and its relationship with other WHO model/priority lists:
| Dr Benedikt David Huttner Team Lead, Essential Medicines List (EML), WHO HQ Dr Wei Zhang Technical Officer, Access to Assistive Technology, WHO HQ Ms Adriana Velázquez Berumen Team Lead, Medical Devices and In Vitro Diagnostics, WHO HQ |
15h11 – 15h31 | EDL at country level: National EDLs | Mr Stephen Himley Technical Officer (Health Technologies), WHO Regional Office for South-East Asia (SEARO) Mr Alexandre Lemgruber Regional Advisor, Health Technologies Management Unit of Medicines and Health Technologies (HSS/MT) |
15h32 – 16h00 | Q&A session |
|
| End of day |
|
For any further queries please contact WHO at EDLSecretariat@who.int. Please visit WHO In vitro diagnostics website.
Disclaimer: By submitting this registration form, you hereby confirm your consent to the World Health Organization (WHO) collecting and processing your personal data (including your name, institutional affiliation, email address) in accordance with WHO’s personal data protection framework for the purpose of event registration and managing attendance, event follow-up, contacting you about future events, and preparing statistics of global event participation by region. Please note that a recording of the event may be made publicly available, for example on the WHO website.